文献速递头颈与中枢神经肿瘤

胶质瘤干细胞特异性超级增强子促进多不饱和脂肪酸合成以支持EGFR信号传导

Glioma Stem Cell-Specific Superenhancer Promotes Polyunsaturated Fatty-Acid Synthesis to Support EGFR Signaling.
PubMed 文献 · Cancer Discov · 2019-06-14

研究对原发性胶质母细胞瘤标本及体外胶质瘤干细胞(GSC)的超级增强子景观进行分析,发现GSC表观遗传上调多不饱和脂肪酸合成关键酶ELOVL2。靶向ELOVL2可抑制胶质母细胞瘤细胞生长与肿瘤起始,并改变膜磷脂组成、破坏膜结构、减弱EGFR信号;联合靶向多不饱和脂肪酸合成与EGFR信号对GSC具有协同细胞毒作用。

要点

  • GSC通过表观遗传上调ELOVL2增强多不饱和脂肪酸合成。
  • 靶向ELOVL2抑制胶质母细胞瘤生长与肿瘤起始。
  • 联合抑制脂肪酸合成与EGFR信号对GSC有协同细胞毒作用。

核心结论

  • GSC利用多不饱和脂肪酸合成维持膜架构并支持EGFR信号,联合靶向该通路与EGFR信号是有前景的治疗策略。

研究设计与样本

  • 研究分析原发性胶质母细胞瘤标本及体外GSC的超级增强子景观,并开展功能实验。

主要发现

  • GSC表观遗传上调ELOVL2,靶向ELOVL2抑制胶质母细胞瘤细胞生长和肿瘤起始。
  • ELOVL2耗竭改变细胞膜磷脂组成、破坏膜结构特性,并通过调控脂肪酸延伸减弱EGFR信号。
  • 联合靶向多不饱和脂肪酸合成与EGFR信号对GSC产生协同细胞毒作用。

临床怎么用

  • 多不饱和脂肪酸合成与EGFR信号联合抑制可能成为靶向GSC的治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Glioblastoma ranks among the most aggressive and lethal of all human cancers. Functionally defined glioma stem cells (GSC) contribute to this poor prognosis by driving therapeutic resistance and maintaining cellular heterogeneity. To understand the molecular processes essential for GSC maintenance and tumorigenicity, we interrogated the superenhancer landscapes of primary glioblastoma specimens and in vitro GSCs. GSCs epigenetically upregulated ELOVL2, a key polyunsaturated fatty-acid synthesis enzyme. Targeting ELOVL2 inhibited glioblastoma cell growth and tumor initiation. ELOVL2 depletion altered cellular membrane phospholipid composition, disrupted membrane structural properties, and diminished EGFR signaling through control of fatty-acid elongation. In support of the translational potential of these findings, dual targeting of polyunsaturated fatty-acid synthesis and EGFR signaling had a combinatorial cytotoxic effect on GSCs. SIGNIFICANCE: Glioblastoma remains a devastating disease despite extensive characterization. We profiled epigenomic landscapes of glioblastoma to pinpoint cell state-specific dependencies and therapeutic vulnerabilities. GSCs utilize polyunsaturated fatty-acid synthesis to support membrane architecture, inhibition of which impairs EGFR signaling and GSC proliferation. Combinatorial targeting of these networks represents a promising therapeutic strategy.See related commentary by Affronti and Wellen, p. 1161.This article is highlighted in the In This Issue feature, p. 1143.

来源:Cancer Discov,查看原文。版权归原作者所有。

引用

  1. Gimple RC, Kidwell RL, Kim LJY, et al. Glioma Stem Cell-Specific Superenhancer Promotes Polyunsaturated Fatty-Acid Synthesis to Support EGFR Signaling. Cancer Discov. 2019. PMID: 31201181. doi:10.1158/2159-8290.CD-19-0061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。